Clinical Trials Logo
  1. Home
  2. Hepatic Steatosis
  3. NCT06298318

Metabolic Changes in Healthy Subjects With Acute Binge Drink — MeABD  

Hepatic Steatosis Clinical Trial

Official title:
Effect of Acute Binge Drink Intervention on Healthy Young Subjects: a Double-blinded, Randomized Trial

Clinical Trial Summary

The goal of this double-blinded, randomized trial is to investigate the effects of acute binge drink on liver function, liver fat content and lipid metabolism in healthy young subjects. The main questions it aims to answer are: 1. if acute binge drink could alleviate liver injury and hepatic steatosis.

Clinical Trial Description

The goal of this double-blinded, randomized trial is to investigate the effects of acute binge drink on liver function, liver fat content and lipid metabolism in healthy young subjects. The main questions it aims to answer are: 1. if acute binge drink could alleviate liver injury and hepatic steatosis. Participants will be randomized into two groups (n=30), and provided vodka(1g/kg body weight) or equal amount of non-alcoholic beverages with the same taste and colour but without alcohol, respectively. 15 minutes later, they are successively provided with same breakfast . Venous blood are collected at 0h, 1h, 2h, 3h, 6h, 12h and 24h from each subject, respectively. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06298318
Study type Interventional
Source Zhejiang Chinese Medical University
Contact
Status Active, not recruiting
Phase N/A
Start date April 27, 2024
Completion date July 18, 2026
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05480696 - Soluble Fibre Supplementation in NAFLD Phase 1
Completed NCT05124847 - TREating Pediatric Obesity N/A
Recruiting NCT05499585 - Treating Pediatric NAFLD With Nutrition N/A
Completed NCT03717935 - Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS N/A
Active, not recruiting NCT02493153 - Hepatic Steatosis After Cholecystectomy N/A
Active, not recruiting NCT05654051 - The SLIM LIVER Study Phase 2
Completed NCT03334214 - Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes Phase 2
Recruiting NCT05599945 - First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases Phase 1
Enrolling by invitation NCT02816814 - Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women N/A
Active, not recruiting NCT03587727 - Hepatic Mitochondrial Function in Youth
Not yet recruiting NCT05935826 - Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study) N/A
Not yet recruiting NCT06394206 - Benefit of a Hospital Intervention in Patients With Hepatic Steatosis N/A
Not yet recruiting NCT06363617 - Implementation of the Fatty Liver Index in Primary Care N/A
Recruiting NCT03142698 - Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis N/A
Completed NCT00480922 - Effects of a Low Glycemic Load Diet on Fatty Liver in Children N/A
Not yet recruiting NCT05871749 - Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B
Recruiting NCT05897073 - Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity N/A
Completed NCT03961516 - Glycemic Characterization and Pancreatic Imaging Correlates in Cystic Fibrosis
Completed NCT04180631 - Quantitative US for Hepatic Steatosis N/A
Terminated NCT00845845 - Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH) Phase 2